A meta-analysis of HLA peptidome composition in different hematological entities: entity-specific dividing lines and “pan-leukemia” antigens

por Backert, Linus, Kowalewski, Daniel Johannes, Walz, Simon, Schuster, Heiko, Berlin, Claudia, Neidert, Marian Christoph, Schemionek, Mirle, Brümmendorf, Tim H., Vucinic, Vladan, Niederwieser, Dietger, Kanz, Lothar, Salih, Helmut Rainer, Kohlbacher, Oliver, Weisel, Katja, Rammensee, Hans-Georg, Stevanović, Stefan, Walz, Juliane Sarah
Publicado 2017

HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy

por Nelde, Annika, Walz, Juliane Sarah, Kowalewski, Daniel Johannes, Schuster, Heiko, Wolz, Olaf-Oliver, Peper, Janet Kerstin, Cardona Gloria, Yamel, Langerak, Anton W., Muggen, Alice F., Claus, Rainer, Bonzheim, Irina, Fend, Falko, Salih, Helmut Rainer, Kanz, Lothar, Rammensee, Hans-Georg, Stevanović, Stefan, Weber, Alexander N. R.
Publicado 2016

HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy

por Marcu, Ana, Bichmann, Leon, Kuchenbecker, Leon, Kowalewski, Daniel Johannes, Freudenmann, Lena Katharina, Backert, Linus, Mühlenbruch, Lena, Szolek, András, Lübke, Maren, Wagner, Philipp, Engler, Tobias, Matovina, Sabine, Wang, Jian, Hauri-Hohl, Mathias, Martin, Roland, Kapolou, Konstantina, Walz, Juliane Sarah, Velz, Julia, Moch, Holger, Regli, Luca, Silginer, Manuela, Weller, Michael, Löffler, Markus W., Erhard, Florian, Schlosser, Andreas, Kohlbacher, Oliver, Stevanović, Stefan, Rammensee, Hans-Georg, Neidert, Marian Christoph
Publicado 2021